tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Verastem announces Nature Medicine publication of FRAME results
PremiumThe FlyVerastem announces Nature Medicine publication of FRAME results
27d ago
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
Premium
Company Announcements
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
27d ago
Verastem price target lowered to $12 from $16 at RBC Capital
Premium
The Fly
Verastem price target lowered to $12 from $16 at RBC Capital
1M ago
Verastem’s Promising Clinical Advances and Strategic Developments Justify Buy Rating
PremiumRatingsVerastem’s Promising Clinical Advances and Strategic Developments Justify Buy Rating
2M ago
Verastem Announces Strategic Plans in Investor Webcast
Premium
Company Announcements
Verastem Announces Strategic Plans in Investor Webcast
2M ago
Verastem Announces Promising Phase 1 Study Results
Premium
Company Announcements
Verastem Announces Promising Phase 1 Study Results
2M ago
Verastem files to sell 3.43M shares of common stock for holders
PremiumThe FlyVerastem files to sell 3.43M shares of common stock for holders
3M ago
Verastem reports Q1 adjusted EPS (79c), two estimates (77c)
Premium
The Fly
Verastem reports Q1 adjusted EPS (79c), two estimates (77c)
3M ago
Verastem price target raised to $13 from $12 at B. Riley
Premium
The Fly
Verastem price target raised to $13 from $12 at B. Riley
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100